Literature DB >> 25104803

The ROKS nomogram for predicting a second symptomatic stone episode.

Andrew D Rule1, John C Lieske2, Xujian Li3, L Joseph Melton4, Amy E Krambeck5, Eric J Bergstralh3.   

Abstract

Most patients with first-time kidney stones undergo limited evaluations, and few receive preventive therapy. A prediction tool for the risk of a second kidney stone episode is needed to optimize treatment strategies. We identified adult first-time symptomatic stone formers residing in Olmsted County, Minnesota, from 1984 to 2003 and manually reviewed their linked comprehensive medical records through the Rochester Epidemiology Project. Clinical characteristics in the medical record before or up to 90 days after the first stone episode were evaluated as predictors for symptomatic recurrence. A nomogram was developed from a multivariable model based on these characteristics. There were 2239 first-time adult kidney stone formers with evidence of a passed, obstructing, or infected stone causing pain or gross hematuria. Symptomatic recurrence occurred in 707 of these stone formers through 2012 (recurrence rates at 2, 5, 10, and 15 years were 11%, 20%, 31%, and 39%, respectively). A parsimonious model had the following risk factors for recurrence: younger age, male sex, white race, family history of stones, prior asymptomatic stone on imaging, prior suspected stone episode, gross hematuria, nonobstructing (asymptomatic) stone on imaging, symptomatic renal pelvic or lower-pole stone on imaging, no ureterovesicular junction stone on imaging, and uric acid stone composition. Ten-year recurrence rates varied from 12% to 56% between the first and fifth quintiles of nomogram score. The Recurrence of Kidney Stone nomogram identifies kidney stone formers at greatest risk for a second symptomatic episode. Such individuals may benefit from medical intervention and be good candidates for prevention trials.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Mesh:

Year:  2014        PMID: 25104803      PMCID: PMC4243346          DOI: 10.1681/ASN.2013091011

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  23 in total

1.  LONG-TERM SURVEY OF 538 PATIENTS WITH UPPER URINARY TRACT STONE.

Authors:  R E WILLIAMS
Journal:  Br J Urol       Date:  1963-12

Review 2.  The first kidney stone.

Authors:  J Uribarri; M S Oh; H J Carroll
Journal:  Ann Intern Med       Date:  1989-12-15       Impact factor: 25.391

3.  The threat to medical-records research.

Authors:  L J Melton
Journal:  N Engl J Med       Date:  1997-11-13       Impact factor: 91.245

4.  Urinary lithiasis in the black population: an epidemiological study and review of the literature.

Authors:  I Sarmina; J P Spirnak; M I Resnick
Journal:  J Urol       Date:  1987-07       Impact factor: 7.450

5.  Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study.

Authors:  A L Strauss; F L Coe; L Deutsch; J H Parks
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

6.  Recurrence after a single renal stone in a community practice.

Authors:  J W Sutherland; J H Parks; F L Coe
Journal:  Miner Electrolyte Metab       Date:  1985

7.  Renal stone epidemiology: a 25-year study in Rochester, Minnesota.

Authors:  C M Johnson; D M Wilson; W M O'Fallon; R S Malek; L T Kurland
Journal:  Kidney Int       Date:  1979-11       Impact factor: 10.612

8.  Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients.

Authors:  A L Strauss; F L Coe; J H Parks
Journal:  Arch Intern Med       Date:  1982-03

9.  Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis.

Authors:  S Millman; A L Strauss; J H Parks; F L Coe
Journal:  Kidney Int       Date:  1982-10       Impact factor: 10.612

10.  Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria.

Authors:  C Y Pak; F Britton; R Peterson; D Ward; C Northcutt; N A Breslau; J McGuire; K Sakhaee; S Bush; M Nicar; D A Norman; P Peters
Journal:  Am J Med       Date:  1980-07       Impact factor: 4.965

View more
  60 in total

1.  Symptomatic and Radiographic Manifestations of Kidney Stone Recurrence and Their Prediction by Risk Factors: A Prospective Cohort Study.

Authors:  Matthew R D'Costa; William E Haley; Kristin C Mara; Felicity T Enders; Terri J Vrtiska; Vernon M Pais; Steven J Jacobsen; Cynthia H McCollough; John C Lieske; Andrew D Rule
Journal:  J Am Soc Nephrol       Date:  2019-06-07       Impact factor: 10.121

2.  Recurrent Calcium Kidney Stones.

Authors:  Lada Beara-Lasic; David S Goldfarb
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-20       Impact factor: 8.237

3.  CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.

Authors:  Marie Dion; Ghada Ankawi; Ben Chew; Ryan Paterson; Nabil Sultan; Patti Hoddinott; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

4.  The metabolic stone evaluation: An opportunity for shared decision-making.

Authors:  Darren Beiko
Journal:  Can Urol Assoc J       Date:  2018-10       Impact factor: 1.862

5.  A nomogram for the prediction of kidney stone recurrence.

Authors:  Brian H Eisner; David S Goldfarb
Journal:  J Am Soc Nephrol       Date:  2014-08-07       Impact factor: 10.121

6.  Stones: ROKS can predict recurrence.

Authors:  Clemens Thoma
Journal:  Nat Rev Urol       Date:  2014-09-02       Impact factor: 14.432

Review 7.  A new era of Asian urology: a SWOT analysis.

Authors:  Rajeev Kumar
Journal:  Nat Rev Urol       Date:  2016-08-23       Impact factor: 14.432

8.  Endoscopic Evidence That Randall's Plaque is Associated with Surface Erosion of the Renal Papilla.

Authors:  Andrew J Cohen; Michael S Borofsky; Blake B Anderson; Casey A Dauw; Daniel L Gillen; Glenn S Gerber; Elaine M Worcester; Fredric L Coe; James E Lingeman
Journal:  J Endourol       Date:  2016-12-20       Impact factor: 2.942

Review 9.  Insights Into Nephrolithiasis From the Nurses' Health Studies.

Authors:  Megan L Prochaska; Eric N Taylor; Gary C Curhan
Journal:  Am J Public Health       Date:  2016-07-26       Impact factor: 9.308

10.  Short-Term Tolvaptan Increases Water Intake and Effectively Decreases Urinary Calcium Oxalate, Calcium Phosphate and Uric Acid Supersaturations.

Authors:  Wisit Cheungpasitporn; Stephen B Erickson; Andrew D Rule; Felicity Enders; John C Lieske
Journal:  J Urol       Date:  2015-11-17       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.